HomeNews

News
R21 vaccinations at Tanzania clinical site,Tom Wilkinson, University of Oxford

R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana

Malaria
Medical Sciences
Research
Vaccines
Close up image of a vaccine dose being prepared from a vial. Image credit: Shutterstock.

£12 million investment for Future Vaccines Manufacturing Hub

Funding
Health
Medical Sciences
Research
Science
Vaccines
Professor Teresa Lambe receives the Irish Abroad award from Irish President Michael D. Higgins - photo by Maxwell Photography

Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award

Awards
Vaccines
Ebola vaccine offers long-lasting immunity

Oxford Ebola vaccine manufactured and shipped in record time by SII

Ebola
Health
Medical Sciences
Vaccines
An illustration that depicts scientists strategising around a drawing of an HIV virus - artwork by Marzia Munafo

EAVI2020: The Quest for an HIV Vaccine

HIV
Research
Vaccines
Artist's impression of an Ebolavirus

Oxford’s Ebola vaccine recommended for deployment against Uganda outbreak

Ebola
Research
Vaccines
Artist's impression of Mycobacterium tuberculosis, the bacteria that causes TB disease

University of Oxford study provides important insights into TB correlates of protection

Research
Vaccines
Artist's impression of an HIV virus

Therapeutic HIV vaccine with Oxford technology achieves encouraging results

HIV
Research
Vaccines
Artist's impression of the meningitis bacteria, also known as meningococcus

MenACWY teenage meningitis vaccine programme drives herd immunity across all ages

Research
Vaccines
A child is vaccinated with the R21 malaria vaccine at Nanoro, Burkina Faso - credit Prof Katie Ewer

Malaria booster vaccine continues to meet WHO-specified 75% efficacy goal

Malaria
Research
Vaccines

Pages